Kristine L. Stump

Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

Lily Lu, Kristine L. Stump, Nate H. Wallace et al. · The Journal of Immunology · 2011 · 75 citations · Full text

Immunology, Immune Regulation, Biological Therapy +25

A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

Kristine L. Stump, Lily Lu, Paweł Dobrzański et al. · Arthritis Research & Therapy · 2011 · 75 citations · Full text

Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE

Matthew M. Seavey, Lily Lu, Kristine L. Stump et al. · International Immunopharmacology · 2011 · 58 citations

Glomerular Disease, Glomerulonephritis, Inflammation +13

Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer

Matthew M. Seavey, Lily Lu, Kristine L. Stump et al. · Molecular Cancer Therapeutics · 2012 · 41 citations

Chemoprevention Strategy, Immunology, Gastroenterology +22

Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001

John T. Poirier, P. Seshidhar Reddy, Neeraja Idamakanti et al. · Journal of General Virology · 2012 · 28 citations

Virus Structure, Viral Replication, Molecular Virology +15